Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

The U.S. military's teledermatology program was effective in providing fast and successful skin care in remote locations, preventing unnecessary evacuations.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Some herbal treatments are effective for skin disorders, but more research and regulation are needed.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

Transplant patients often get skin problems, with treatments varying by condition.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Adding cells to fat grafts improves hair regrowth in early baldness, but effects lessen over time.

The document emphasizes the need for primary care providers to understand and care for African American children's hair and skin to boost their self-esteem.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.